Atos renews “Choose French Tech” pledge, targets higher sourcing and pilot deployments with French startups

Atossa Therapeutics, Inc.

Atossa Therapeutics, Inc.

ATOS

0.00
  • Atos renewed its participation in France’s “Je choisis la French Tech” program to expand planned collaboration with French start-ups.
  • Work will focus on a roadmap with Mission French Tech to increase start-up sourcing, pilots, deployments, procurement targets, monitoring.
  • Priority investment areas include AI-driven cybersecurity, agentic AI, digital sovereignty, with additional focus on smart cities, climate resilience, industry.
  • Execution will run through the Scaler program, supported by the Inno’Labs network to identify start-ups regionally, industrialize solutions for clients.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AtoS SE published the original content used to generate this news brief on June 17, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.